184 related articles for article (PubMed ID: 1314086)
21. Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor status.
Geisler J; Suzuki T; Helle H; Miki Y; Nagasaki S; Duong NK; Ekse D; Aas T; Evans DB; Lønning PE; Sasano H
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):237-41. PubMed ID: 19883757
[TBL] [Abstract][Full Text] [Related]
22. Comparison of serum oestrogen concentrations in post-menopausal women taking oestrone sulphate and oestradiol.
Anderson AB; Sklovsky E; Sayers L; Steele PA; Turnbull AC
Br Med J; 1978 Jan; 1(6106):140-2. PubMed ID: 620226
[TBL] [Abstract][Full Text] [Related]
23. The effect of ethynyloestradiol and medroxyprogesterone acetate on the in vivo uptake and metabolism of 3H-oestradiol by breast tumour tissue in postmenopausal women.
Reed MJ; Beranek PA; Bonney RC; Ghilchik MW; James VH
Anticancer Res; 1987; 7(6):1265-9. PubMed ID: 2831795
[TBL] [Abstract][Full Text] [Related]
24. 17 Beta-hydroxysteroid dehydrogenase and aromatase activity in breast fat from women with benign and malignant breast tumours.
Beranek PA; Folkerd EJ; Ghilchik MW; James VH
Clin Endocrinol (Oxf); 1984 Feb; 20(2):205-12. PubMed ID: 6325047
[TBL] [Abstract][Full Text] [Related]
25. Aromatase activity in breast tissue.
Miller WR
J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):783-90. PubMed ID: 1954167
[TBL] [Abstract][Full Text] [Related]
26. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway.
Santner SJ; Feil PD; Santen RJ
J Clin Endocrinol Metab; 1984 Jul; 59(1):29-33. PubMed ID: 6725522
[TBL] [Abstract][Full Text] [Related]
27. Oestrogen production and metabolism in peri-menopausal women.
Reed MJ; Beranek PA; James VH
Maturitas; 1986 Mar; 8(1):29-34. PubMed ID: 3084922
[TBL] [Abstract][Full Text] [Related]
28. Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors.
Lønning PE; Haynes BP; Dowsett M
Eur J Cancer; 2014 Apr; 50(6):1055-64. PubMed ID: 24507547
[TBL] [Abstract][Full Text] [Related]
29. Steroid sequestration and tightly bound oestrogen-protein complexes in human breast tumours and a breast cancer cell line.
Anderson E; Vinson GP; Puddefoot JR; Raven PW; Gilmore OJ
J Steroid Biochem; 1986 Feb; 24(2):489-95. PubMed ID: 3702435
[TBL] [Abstract][Full Text] [Related]
30. Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status.
Lønning PE; Helle H; Duong NK; Ekse D; Aas T; Geisler J
J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):31-41. PubMed ID: 19591931
[TBL] [Abstract][Full Text] [Related]
31. Oestrone sulphate in plasma from postmenopausal women and the effects of oestrogen and androgen therapy.
Towobola OA; Crilly RC; Oakey RE
Clin Endocrinol (Oxf); 1980 Nov; 13(5):461-71. PubMed ID: 6261992
[TBL] [Abstract][Full Text] [Related]
32. Estrone sulfate and sulfatase activity in human breast cancer and endometrial cancer.
Naitoh K; Honjo H; Yamamoto T; Urabe M; Ogino Y; Yasumura T; Nambara T
J Steroid Biochem; 1989 Dec; 33(6):1049-54. PubMed ID: 2559248
[TBL] [Abstract][Full Text] [Related]
33. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
[TBL] [Abstract][Full Text] [Related]
34. [Evidence, in vitro, of estrone and estradiol-17 beta 3-sulfoconjugate hydrolysis in the uterus of pregnant guinea pigs].
Adessi GL; Nhuan TQ; Goutte-Coussieu C; Jayle MF
C R Seances Acad Sci III; 1981 Mar; 292(9):609-12. PubMed ID: 6263512
[TBL] [Abstract][Full Text] [Related]
35. Effects of plasma estrogen sulfates in mammary cancer cells.
Vignon F; Terqui M; Westley B; Derocq D; Rochefort H
Endocrinology; 1980 Apr; 106(4):1079-86. PubMed ID: 6244140
[No Abstract] [Full Text] [Related]
36. Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole.
de Jong PC; van de Ven J; Nortier HW; Maitimu-Smeele I; Donker TH; Thijssen JH; Slee PH; Blankenstein RA
Cancer Res; 1997 Jun; 57(11):2109-11. PubMed ID: 9187104
[TBL] [Abstract][Full Text] [Related]
37. Conjugated and unconjugated oestrogens in fetal and maternal fluids of the cow throughout pregnancy.
Robertson HA; King GJ
J Reprod Fertil; 1979 Mar; 55(2):463-70. PubMed ID: 220418
[TBL] [Abstract][Full Text] [Related]
38. Human testis does not secrete oestrone sulphate.
Wu FC; Swanston IA; Hargreave TB; Baird DT
J Endocrinol; 1982 Feb; 92(2):185-94. PubMed ID: 6278041
[TBL] [Abstract][Full Text] [Related]
39. Oestradiol: the predominant intranuclear oestrogen in the endometrium of oestrogen-treated postmenopausal women.
Whitehead MI; Lane G; Dyer G; Townsend PT; Collins WP; King RJ
Br J Obstet Gynaecol; 1981 Sep; 88(9):914-8. PubMed ID: 7272264
[TBL] [Abstract][Full Text] [Related]
40. Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression.
Bhardwaj P; Au CC; Benito-Martin A; Ladumor H; Oshchepkova S; Moges R; Brown KA
J Steroid Biochem Mol Biol; 2019 May; 189():161-170. PubMed ID: 30851382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
